Your browser doesn't support javascript.
loading
Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment.
Tomlins, Scott A; Day, John R; Lonigro, Robert J; Hovelson, Daniel H; Siddiqui, Javed; Kunju, L Priya; Dunn, Rodney L; Meyer, Sarah; Hodge, Petrea; Groskopf, Jack; Wei, John T; Chinnaiyan, Arul M.
Afiliación
  • Tomlins SA; Michigan Center for Translational Pathology, Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI, USA. E
  • Day JR; Hologic/Gen-Probe Inc., San Diego, CA, USA.
  • Lonigro RJ; Michigan Center for Translational Pathology, Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Hovelson DH; Department of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Siddiqui J; Michigan Center for Translational Pathology, Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Kunju LP; Michigan Center for Translational Pathology, Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Dunn RL; Department of Urology, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Meyer S; Hologic/Gen-Probe Inc., San Diego, CA, USA.
  • Hodge P; Hologic/Gen-Probe Inc., San Diego, CA, USA.
  • Groskopf J; Hologic/Gen-Probe Inc., San Diego, CA, USA.
  • Wei JT; Department of Urology, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Chinnaiyan AM; Michigan Center for Translational Pathology, Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI, USA; D
Eur Urol ; 70(1): 45-53, 2016 07.
Article en En | MEDLINE | ID: mdl-25985884
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Próstata / Neoplasias de la Próstata / Proteínas de Fusión Oncogénica / Antígeno Prostático Específico / Antígenos de Neoplasias Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Eur Urol Año: 2016 Tipo del documento: Article Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Próstata / Neoplasias de la Próstata / Proteínas de Fusión Oncogénica / Antígeno Prostático Específico / Antígenos de Neoplasias Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Eur Urol Año: 2016 Tipo del documento: Article Pais de publicación: Suiza